RxDoctor Payments Data

Michael Mumma

Cardiovascular Disease · Sarasota, FLNPI 1700896115

Payments from drug & device makers

$66,081in general payments, 2019–2025

Across 176 payments — averaging $375.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim International GmbH$52K
  • Boehringer Ingelheim Pharma GmbH & Co.kg$13K
  • Boston Scientific$1K
  • Amgen$134
  • Johnson & Johnson$106
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$77
  • plus $217 from 7 others

What the payments were for

  • Travel & lodging$94255%
  • Food & beverage$76045%

General payments by program year

19
20
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$66,081 in reported general payments places this provider in the 85th percentile of 1,740 cardiovascular disease providers in Florida.

See all cardiovascular disease providers in Florida

Other cardiovascular disease in Sarasota

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →